Events

Please join us for the 94th in our series “Changing the Way We Work” on Friday July 18, 2025. In this session, we will share a brief overview on infectious disease and discuss TB test interpretation and treatment for latent TB.

New nicotine delivery systems, policies and evidence are evolving to include nicotine pouches, ‘heat sticks’, and vaping products. Family physicians may be unfamiliar with emerging products and evidence and unable to provide guidance to patients.

Long-term care (LTC) residents are more dependent, frail and vulnerable, and require more complex care than community-dwelling older adults. Yet many interventions intended to reduce fracture risk are not used consistently in LTC, and clinical practice guidelines for osteoporosis have focused on the care of adults living in the community.

Even if a family doctor makes the correct diagnosis and prescribes the most appropriate treatment to address an illness, if a patient is unable to access the treatment due to social or financial circumstances the patient will not improve.

The CFPC Certification Exam Orientation workshop provides an introduction to the CFPC certification exam components. Participants have the opportunity to practice a mini Short Answer Management Problems (SAMPS) exam and participate in four practice Simulated Office Orals (SOOs).

Administrative burden, including completing complex forms and reviewing EMRs are all contributing to burnout in family medicine. During this session, our panelists will discuss tricks to efficiently review EMRs, setting boundaries with patients, taking vacations and training your office staff to take on some of the burdensome tasks.

Since 2018, patients have been able to access medical cannabis that has been authorized by a physician who signs a medical document. New research supporting the therapeutic use, safety and efficacy on cannabis is only now emerging, which puts family physicians in a difficult position as they may be asked to authorize cannabis when they are not familiar with the process.

There is growing interest in the use of psychedelics for the treatment of PTSD, depression and substance use disorders. Patients may ask their provider about these options, but family physicians are unaware of the latest data on safety and efficacy or understand what services are available in Ontario.

Collectively, physicians faced and/or continue to face a trauma related to caring for patients during the COVID-19 pandemic. However, few family physicians have had the opportunity to collectively discuss this.